Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

Affiliations

Hong Qin: Research and Development Department, NanHua Bio-medicine CO., Ltd., Changsha, China
Changqiao You: Research and Development Department, NanHua Bio-medicine CO., Ltd., Changsha, China
Feng Yan: Research and Development Department, NanHua Bio-medicine CO., Ltd., Changsha, China
Kefang Tan: Research and Development Department, NanHua Bio-medicine CO., Ltd., Changsha, China
Changgen Xu: Research and Development Department, NanHua Bio-medicine CO., Ltd., Changsha, China
Rui Zhao: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
Marlene Davis Ekpo: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
Songwen Tan: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/